Elevated plasma testosterone concentrations from males on testosterone replacement therapy are mitigated with pathogen reduction technology

Documenti analoghi

• Compound adsorption device in pathogen reduction technology removes multiple drugs from plasma components
  di: Briana Greenwall, et al.
  Pubblicazione: (2025)
• Stored platelet hemostatic phenotype and function is not altered when donors are on testosterone replacement therapy
  di: Alisha Chitrakar, et al.
  Pubblicazione: (2024)
• Quantifying the impact of a novel virus on the economic value of pathogen reduction technology for platelets
  di: Adam Irving, et al.
  Pubblicazione: (2024)
• Implementing pathogen reduction technology while discontinuing blood donor deferral criteria for sexual risk behaviors: A simulation study
  di: Marie‐Pier Domingue, et al.
  Pubblicazione: (2024)
• On lower fibrinogen threshold for fibrinogen replacement in plasma exchange: Perhaps for patients with no bleeding risk, but there are more shades of gray
  di: Matej Zrimsek, et al.
  Pubblicazione: (2025)